FEDERAL STREET STRATEGIES, LLC

Lobbying for BIOGEN, INC. · Biotechnology Company.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $50,000.00 income · posted Oct 20, 2025

Lobbying activity 3

Health Issues

Monitoring issues related to Alzheimer's Disease and treatment. Amyotrophic lateral sclerosis (ALS), Lou Gehrigs Disease and treatment. Monitor issues related to the FY2026 budget process

Medicare/Medicaid

Issues related to rare diseases and treatment. Issues related to Mental Health treatment. Issues related to maternal health. Monitor issues related to the FY2026 budget process

Taxation/Internal Revenue Code

Issues related to tax reform and the FY2026 budget process

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.